All
  • All
  • Insight
  • Research Services
  • Preclinical CRO
  • Animal Resource Bank

Bone-related disease model


Aniphe BioLab develops bone and skeletal disease models based on established disease mechanisms and standardized modeling protocols, supporting research on bone metabolic disorders, inflammatory bone destruction, and skeletal degeneration.
By reproducing imbalances in bone resorption and formation, articular cartilage degeneration, and inflammatory microenvironment changes, our models provide reliable in vivo platforms for disease mechanism studies and drug evaluation. Applications include orthopedic drug development, anti-inflammatory drug evaluation, and bone regenerative material research, particularly in osteoporosis, osteoarthritis, and rheumatoid arthritis.

Explore more

dots1.png
Mechanism-oriented
Precision Modeling
dots2.png
Multiple reviews
System Verification
dots3.png
Phenotypic stability
Repeatability
dots4.png
University Support
Accelerate R&D
Bone-related disease model

Characteristics of Aniphe BioLab Bone-Related Disease Models

Leveraging a standardized animal model platform and extensive experience in long-term pharmacological efficacy evaluation, Jiangsu Ailingfei Biotechnology Co., Ltd. has established a systematic, reproducible, and scalable animal model system for bone-related diseases, tailored to research needs in this field, with the following key features:

 

 Comprehensive model coverage

Comprehensive model coverage
We offer mainstream disease models, including osteoporosis, osteoarthritis, and rheumatoid arthritis, to meet the needs of mechanistic research and drug efficacy evaluation.

 Standardization of the modeling process

  Standardization and stability of model establishment
Standardized SOP-based process management ensures consistent data across batches by standardizing every step, from animal selection and model‑generation methods to sampling time points.

 Multidimensional Evaluation System

  Multidimensional evaluation system
Supports a three-tiered assessment of bone structure, inflammation, and function, including: micro-CT–based bone structural analysis, histopathological examination (e.g., H&E, TRAP), inflammatory cytokine assays, and behavioral and pain assessments.

 Standardization of Data Delivery

End-to-end data traceability
We provide raw data, imaging results, and standardized reports to meet the requirements for manuscript publication and grant applications.

 

The animal model system for diseases related to the alveolar bone, with a focus on stability, reproducibility, and translational efficacy, provides a reliable experimental foundation for orthopedic drug development and mechanistic studies.
 

Product List:


Disease Name

Disease model

Details

 Comprehensive model coverage Glioblastoma

U87-MG-luc orthotopic animal model

View details →

 Comprehensive model coverage Alzheimer's disease

Alzheimer’s disease AD animal model

View details →

 Comprehensive model coverage Encephalomyelitis

Allergic encephalomyelitis animal model of AE

View details →

 Comprehensive model coverage Post-traumatic stress disorder

Animal model of post-traumatic stress disorder (PTSD)

View details →

 Comprehensive model coverage Traumatic brain injury

Animal model of traumatic brain injury

View details →

 Comprehensive model coverage Epilepsy

Epilepsy animal model

View details →

 Comprehensive model coverage Spinal cord injury

Animal model of spinal cord injury

View details →

 Comprehensive model coverage Anxiety disorder

Anxiety disorder animal model

View details →

 Comprehensive model coverage Neurological dysfunction after TBI

Animal model of traumatic brain injury with electrical stimulation

View details →

 Comprehensive model coverage Traumatic brain injury

Animal model of traumatic brain injury

View details →

 Comprehensive model coverage Depression

Chronic Unpredictable Mild Stress (CUMS) animal model

View details →

 Comprehensive model coverage Hemorrhagic stroke

Animal model of cerebral hemorrhage

View details →

 

Cerebral ischemia MCAO animal model

View details →

 Comprehensive model coverage Sepsis-associated encephalopathy

Sepsis-induced brain injury model

View details →

 Comprehensive model coverage Parkinson's disease

Parkinson’s disease (PD) animal model

View details →

 Comprehensive model coverage Hepatic encephalopathy (early stage)

Mild hepatic encephalopathy model

View details →

 Comprehensive model coverage Hypoxic-ischemic brain injury

Hypoxic-ischemic encephalopathy (HIE) animal model

View details →

 Comprehensive model coverage Trigeminal neuralgia

Trigeminal neuralgia animal model

View details →

 Comprehensive model coverage Sleep disorder

Animal models of sleep disorders/insomnia

View details →

 Comprehensive model coverage Vascular dementia

Vascular dementia animal model

View details →

 Comprehensive model coverage Depression

Animal model of depression

View details →

 Comprehensive model coverage Multiple sclerosis

Animal model of autoimmune encephalomyelitis

View details →

 Comprehensive model coverage Neuropathic pain

Sciatic nerve compression animal model

View details →

 

Disease Name

Disease model

Construction method

 Comprehensive model coverage Migraine

Migraine model

Nitroglycerin injection, dural inflammation-induced stimulation (application of inflammatory substances)

 Comprehensive model coverage Hypopituitarism

Pituitaryectomy model

Surgical removal of the pituitary gland (via the transsphenoidal or transcranial approach)

 Comprehensive model coverage Suppurative osteomyelitis

Experimental model of osteomyelitis

Tibial drilling and injection of Staphylococcus aureus

 Comprehensive model coverage Ischemic tolerance induction

Hypoxic preconditioning model

Severe ischemia is induced following repeated brief hypoxic exposures (in normobaric or hypobaric chambers).

 Comprehensive model coverage Vestibular dysfunction

Unilateral labyrinthectomy model

Surgical destruction of the unilateral vestibular organ in rats and guinea pigs.

 Comprehensive model coverage Antipsychotic-induced bone loss

Schizophrenia-induced osteoporosis model

Long-term administration of antipsychotic agents (such as haloperidol) in combination with ovariectomy or glucocorticoid induction

 Comprehensive model coverage Periprosthetic osteolysis

Cranial bone dissolution model

Cranial implantation of titanium particles or inflammatory factors (TNF-α/polyethylene particles)

 Comprehensive model coverage Post-ischemic epilepsy

Global cerebral ischemic epilepsy model

Seizures following bilateral common carotid artery ligation combined with hypotension-induced ischemia

Disease Name

Disease model

Details

Animal model of avascular necrosis of the femoral head

Osteoarthritis (OA) animal model

Animal model of fracture

Osteoporosis animal model

Animal model of articular cartilage defects

Closed tibial fracture animal model

Animal model of knee joint cartilage injury

Animal model of mandibular defect

Animal model of lumbar disc degeneration

Disease Name

Disease model

Construction method

Muscle injury/hematoma

Rat blunt muscle contusion model

Pneumatic impactor striking the quadriceps femoris muscle

Complete spinal cord injury

Spinal cord hemisection model

Laminectomy at T9–T10 combined with hemisection of the spinal cord

Gout model

Gouty Arthritis Model

Resection of an 8-mm segment of the midshaft of the tibia.

Bone Regeneration Assessment

Femoral Diaphyseal Bone Defect Model

Femoral ankle drilling

Meniscus tear

Full-thickness meniscal injury model

Longitudinal full-thickness incision of the meniscal body

Hyperthyroidism

Hyperthyroidism model

Levothyroxine gavage

Ankylosing spondylitis

Ankylosing spondylitis model

Spontaneous inflammation driven by the immune-genetic–gut–joint axis

TNF-Mut Arthritis

TNF-α transgenic arthritis model

Joint destruction driven by a single inflammatory cytokine (TNF)